Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Depreciation & Amortization (IS) (2016 - 2021)

Abeona Therapeutics (ABEO) has 11 years of Depreciation & Amortization (IS) data on record, last reported at $807000.0 in Q4 2021.

  • For Q4 2021, Depreciation & Amortization (IS) fell 3.93% year-over-year to $807000.0; the TTM value through Dec 2021 reached $3.2 million, down 29.13%, while the annual FY2021 figure was $3.2 million, 29.13% down from the prior year.
  • Depreciation & Amortization (IS) reached $807000.0 in Q4 2021 per ABEO's latest filing, up from $802000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $2.1 million in Q1 2020 and bottomed at $138000.0 in Q3 2017.
  • Average Depreciation & Amortization (IS) over 5 years is $878105.3, with a median of $817000.0 recorded in 2021.
  • Peak YoY movement for Depreciation & Amortization (IS): skyrocketed 852.87% in 2019, then plummeted 60.44% in 2021.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $146000.0 in 2017, then soared by 852.74% to $1.4 million in 2018, then skyrocketed by 46.08% to $2.0 million in 2019, then tumbled by 58.66% to $840000.0 in 2020, then fell by 3.93% to $807000.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (IS) were $807000.0 in Q4 2021, $802000.0 in Q3 2021, and $824000.0 in Q2 2021.